Eli Lilly invites you to an expert discussion on evolving approaches to the diagnosis and treatment of Alzheimer’s disease (AD), featuring leading neurologists Dr. Sidharth Shankar Anand, Dr. Sudhir Kumar, and Dr. Faheem Arshad. The experts will share their perspectives and clinical experiences through real-world cases involving blood biomarkers and amyloid-targeting therapies in people with early symptomatic Alzheimer’s disease.

The session will also explore the evidence supporting the use of blood biomarkers for accurate diagnosis of AD. Join the experts on August 11 , 2026 , from 8:00 PM to 9:00 PM IST for practical insights into the evolving approaches to AD diagnosis and treatment. We look forward to welcoming you to this insightful session. Agenda : ##Disclaimer## The information provided in this section is intended solely for the use of registered medical practitioners. This…